J. Goldman & Co’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,700
| Closed | -$204K | – | 437 |
|
|
2024
Q2 | $204K | Buy |
+2,700
| New | +$204K | 0.01% | 283 |
|
|
2024
Q1 | – | Sell |
-17,694
| Closed | -$1.11M | – | 363 |
|
|
2023
Q4 | $1.11M | Buy |
17,694
+9,010
| +104% | +$566K | 0.05% | 145 |
|
|
2023
Q3 | $443K | Sell |
8,684
-367
| -4% | -$18.7K | 0.02% | 181 |
|
|
2023
Q2 | $452K | Buy |
9,051
+230
| +3% | +$11.5K | 0.02% | 195 |
|
|
2023
Q1 | $331K | Sell |
8,821
-28,219
| -76% | -$1.06M | 0.01% | 202 |
|
|
2022
Q4 | $1.78M | Buy |
37,040
+15,872
| +75% | +$761K | 0.09% | 143 |
|
|
2022
Q3 | $508K | Buy |
+21,168
| New | +$508K | 0.02% | 207 |
|